Valuation: Stratec SE

Market Cap 22Cr 25Cr 20Cr 19Cr 36Cr 2.41TCr 36Cr 244.09Cr 95Cr 1.18TCr 95Cr 93Cr 4.08TCr P/E 2026 *
17.7x
P/E 2027 * 12.1x
Enterprise Value 32Cr 37Cr 30Cr 28Cr 52Cr 3.51TCr 53Cr 355.07Cr 138.03Cr 1.72TCr 138.19Cr 135.22Cr 5.94TCr EV / Sales 2026 *
1.2x
EV / Sales 2027 * 1.12x
Free-Float
49.38%
Yield 2026 *
3.69%
Yield 2027 * 4.24%
1 day+4.49%
1 week+4.74%
Current month+6.46%
1 month+6.71%
3 months+4.14%
6 months-18.01%
Current year-18.19%
1 week 16.4
Extreme 16.4
18.12
1 month 16.4
Extreme 16.4
18.78
Current year 16.38
Extreme 16.38
23.9
1 year 16.38
Extreme 16.38
32.2
3 years 16.38
Extreme 16.38
60.7
5 years 16.38
Extreme 16.38
144.8
10 years 16.38
Extreme 16.38
145.2
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2011
Director of Finance/CFO 38 01/11/2025
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 29/05/2019
Chairman 68 20/05/2022
Director/Board Member 73 21/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.49%+4.74% - - 25Cr
-1.52%+1.29%+22.51%-0.84% 19TCr
+1.29%+6.11%-19.43%+30.49% 15TCr
-2.59%-0.36%-3.78%-18.05% 14TCr
-1.40%+1.72%-57.40%-16.36% 6.71TCr
+0.54%+3.70%+23.29%+4.52% 5.43TCr
-0.26%+2.41%-25.15%-29.38% 4.46TCr
-0.87%+1.59%+8.08%+41.41% 3.72TCr
+0.03%-1.83%+9.35%+10.11% 3.69TCr
+4.79%+10.61%-14.40%+2.09% 3.02TCr
Average +0.47%+2.74%-6.33%+2.67% 8.4TCr
Weighted average by Cap. -0.55%+3.44%-3.41%+2.28%

Financials

2026 *2027 *
Net sales 27Cr 31Cr 25Cr 23Cr 43Cr 2.91TCr 44Cr 294.72Cr 114.57Cr 1.43TCr 114.7Cr 112.24Cr 4.93TCr 28Cr 32Cr 26Cr 24Cr 46Cr 3.09TCr 47Cr 313.19Cr 121.75Cr 1.52TCr 121.89Cr 119.27Cr 5.24TCr
Net income 1.4Cr 1.6Cr 1.29Cr 1.2Cr 2.28Cr 152.73Cr 2.31Cr 15Cr 6.01Cr 75Cr 6.02Cr 5.89Cr 258.7Cr 1.83Cr 2.09Cr 1.68Cr 1.57Cr 2.97Cr 199.16Cr 3.02Cr 20Cr 7.84Cr 98Cr 7.85Cr 7.68Cr 337.35Cr
Net Debt 10Cr 12Cr 9.24Cr 8.62Cr 16Cr 1.1TCr 17Cr 110.98Cr 43Cr 538.56Cr 43Cr 42Cr 1.86TCr 9.77Cr 11Cr 8.98Cr 8.37Cr 16Cr 1.06TCr 16Cr 107.79Cr 42Cr 523.06Cr 42Cr 41Cr 1.8TCr
Logo Stratec SE
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Employees
1,395
Date Price Change Volume
06/26/06 18.12 +2.95% 0
03/26/03 €17.60 -1.68% 0
02/26/02 €17.90 +9.15% 60
01/26/01 €16.40 -3.64% 0
30/26/30 €17.02 -1.62% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
18.20EUR
Average target price
25.40EUR
Spread / Average Target
+39.56%

Annual profits - Rate of surprise